Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Raje

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Leukemia|May 30, 2008
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus StatementM A Hussein, F D Vrionis, R Allison, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Leukemia|May 30, 2008
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus StatementM A Hussein, F D Vrionis, R Allison, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Pageof 6